UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 9)*
| Community First, Inc. |
(Name of issuer)
| Common Stock, no par value |
(Title of class of securities)
| 203663 10 9 |
(CUSIP number)
| May 18, 1999 |
(Date of event which requires filing of this statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
¨ Rule 13d-1(b)
þ Rule 13d-1(c)
¨ Rule 13d-1(d)
| * | The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
SCHEDULE 13G
| CUSIP No. 203663 10 9 | Page 2 of 5 Pages |
| (1) | Names of reporting persons
Eslick E. Daniel, M.D. | |||||
| (2) | Check the appropriate box if a member of a group (see instructions) (a) ¨ (b) ¨
| |||||
| (3) | SEC use only
| |||||
| (4) | Citizenship or place of organization
United States of America | |||||
Number of shares beneficially owned by each reporting person with: | (5) | Sole voting power
56,694 | ||||
| (6) | Shared voting power
157,638 | |||||
| (7) | Sole dispositive power
56,694 | |||||
| (8) | Shared dispositive power
157,638 | |||||
(9) | Aggregate amount beneficially owned by each reporting person
214,332 | |||||
(10) | Check if the aggregate amount in Row (9) excludes certain shares (see instructions)
¨ | |||||
(11) | Percent of class represented by amount in Row (9)
6.54% | |||||
(12) | Type of reporting person (see instructions)
IN | |||||
Page 3 of 5 Pages
Item 1(a). Name of Issuer: | Community First, Inc. | |
Item 1(b). Address of Issuer’s Principal Executive Offices: | 501 S. James M. Campbell Columbia, TN 38401 | |
Item 2(a). Name of Person Filing: | See Item 1 of page 2 | |
Item 2(b). Address of Principal Business Office or, if none, Residence: | 1223 1/2 Trotwood Avenue Columbia, TN 38401 | |
Item 2(c). Organization/Citizenship: | See Item 4 of page 2 | |
Item 2(d). Title of Class Of Securities: | Common Stock, no par value | |
Item 2(e). CUSIP Number: | 203663 10 9 | |
Item 3. Inapplicable. | ||
Item 4. Ownership. | ||
Person | Total Shares of Common Stock Beneficially Owned | Percent of Class(1) | Sole Voting Power | Shared Voting Power | Sole Power to Dispose | Shared Power to Dispose | ||||||||||||||||||
Eslick E. Daniel, M.D. | 214,332 | 6.54 | % | 56,694 | 157,638 | 56,694 | 157,638 | |||||||||||||||||
| (1) | Based on 3,274,946 shares of Common Stock outstanding as of December 31, 2014. |
Page 4 of 5 Pages
| Item 5. | Ownership of Five Percent or Less of a Class. |
Inapplicable
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person. |
Inapplicable
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. |
Inapplicable
| Item 8. | Identification and Classification of Members of the Group. |
Inapplicable
| Item 9. | Notice of Dissolution of Group. |
Inapplicable
| Item 10. | Certification. |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
Page 5 of 5 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
February 10, 2015 |
Date |
/s/ Eslick E. Daniel, M.D. |
(Signature) |
Eslick E. Daniel, M.D. |
(Name/Title) |
